Pro-drug strategies for pancreatic cancer therapy
Thesis
(2018). Pro-drug strategies for pancreatic cancer therapy
Pancreatic cancer is the fourth main cancer in the western world. Currently the only chemotherapy available clinically is gemcitabine. However, gemcitabine treatment only proves effective in 23.8% of patients. Nano-structures (<120 nm) are capable of...